Prophylaxis with carnosol attenuates liver injury induced by intestinal ischemia/reperfusion

Ji-Hong Yao; Xue-Song Zhang; Shu-Sen Zheng; Ying-Hua Li; Li-Ming Wang; Zhen-Zhen Wang; Liang Chu; Xiao-Wei Hu; Ke-Xin Liu; Xiao-Feng Tian; Naito, Yuji
July 2009
World Journal of Gastroenterology;7/14/2009, Vol. 15 Issue 26, p3240
Academic Journal
AIM: To investigate the possible protective effects of carnosol on liver injury induced by intestinal ischemia reperfusion (I/R). METHODS: Rats were divided randomly into three experimental groups: sham, intestinal I/R and carnosol treatment (n = 18 each). The intestinal I/R model was established by clamping the superior mesenteric artery for 1 h. In the carnosol treatment group, surgery was performed as in the intestinal I/R group, with intraperitoneal administration of 3 mg/kg carnosol 1 h before the operation. At 2, 4 and 6 h after reperfusion, rats were killed and blood, intestine and liver tissue samples were obtained. Intestine and liver histology was investigated. Serum levels of aspartate aminotransferase (AST), alanine aminotransferase (ALT) and interleukin (IL)-6 were measured. Liver tissue superoxide dismutase (SOD) and myeloperoxidase (MPO) activity were assayed. The liver intercellular adhesion molecule-1 (ICAM-1) and nuclear factor κB (NF-κB) were determined by immunohistochemical analysis and western blot analysis. RESULTS: Intestinal I/R induced intestine and liver injury, characterized by histological changes, as well as a significant increase in serum AST and ALT levels. The activity of SOD in the liver tissue decreased after I/R, which was enhanced by carnosol pretreatment. In addition, compared with the control group, carnosol markedly reduced liver tissue MPO activity and serum IL-6 level, which was in parallel with the decreased level of liver ICAM-1 and NF-κB expression. CONCLUSION: Our results indicate that carnosol pretreatment attenuates liver injury induced by intestinal I/R, attributable to the antioxidant effect and inhibition of the NF-κB pathway.


Related Articles

  • Febuxostat Improves the Local and Remote Organ Changes Induced by Intestinal Ischemia/Reperfusion in Rats. Shafik, Amani // Digestive Diseases & Sciences;Mar2013, Vol. 58 Issue 3, p650 

    Background: Xanthine oxidase has been implicated in the pathogenesis of a wide spectrum of diseases, and is thought to be the most important source of oxygen-free radicals and cell damage during re-oxygenation of hypoxic tissues. Aims: The present study was undertaken to demonstrate whether...

  • Which pathways trigger the role of complement in ischemia/reperfusion injury? Farrar, Conrad A.; Asgari, Elham; Schwaeble, Wilhelm J.; Sacks, Steven H. // Frontiers in Immunology;Nov2012, Vol. 3, p1 

    Investigations into the role of complement in ischemia/reperfusion (I/R) injury have identified common effector mechanisms that dependonthe productionofC5a and C5b-9 through the cleavage of C3. These studies have also defined an important role for C3 synthesized within ischemic kidney. Less...

  • Development of Blood Biomarkers for Drug-Induced Liver Injury: An Evaluation of Their Potential for Risk Assessment and Diagnostics. Amacher, David E.; Schomaker, Shelli J.; Aubrecht, Jiri // Molecular Diagnosis & Therapy;Dec2013, Vol. 17 Issue 6, p343 

    Drug-induced liver injury (DILI) remains a rare but serious complication in drug therapy that is a primary cause of drug failure during clinical trials. Conventional biomarkers, particularly the serum transaminases and bilirubin, serve as useful indicators of hepatocellular or cholestatic liver...

  • FDA actions. Elliott, William T. // Infectious Disease Alert;Apr2011 Pharmacology Watch, p2 

    The article focuses on several drug actions of the U.S. Food and Drug Administration (FDA). These include a warning issued against using terbutaline for prolonged treatment or prevention of preterm labor among pregnant women and the drug safety alert issued on the risk of serious liver injury in...

  • Hepatotherapeutic Effect of Aloe Vera in Alcohol-induced Hepatic Damage. Saka, W. A.; Akhrgbe, R. E.; Ishola, O. S.; Ashamu, E. A.; Olayemi, O. T.; Adeleke, G. E. // Pakistan Journal of Biological Sciences;7/15/2011, Vol. 14 Issue 14, p742 

    There is a lack of reliable hepatotherapeutic drugs in modern medicine in the management of alcohol/drug-induced liver damage. Aloe vera extract has been used in folklore medicine for its medicinal values. This study evaluates the hepatotherapeutic activity of aqueous extract of Aloe vera gel in...

  • Paracetamol: the forgotten drug. Mehta, V.; Shah, S. // British Journal of Hospital Medicine (17508460);Nov2010, Vol. 71 Issue 11, p606 

    The author reflects on Paracetamol, one of the commonly used drugs worldwide. Different aspects of the drug is discussed including the history of its inception in 1878, and the mechanism of its action. The author also highlights the side effects of the drug which is a known hepatotoxic drug...

  • Bosentan.  // Reactions Weekly;10/3/2009, Issue 1272, p10 

    The article presents a case study of liver injury in a 56-year-old woman caused by bosentan. She has pulmonary hypertension secondary to scleroderma. After bosentan was consumed, jaundice and right hypochondrium pain were experienced. Cholestasis and hepatic cytolysis were observed upon...

  • Predictive Genetic Testing for Drug-Induced Liver Injury: Considerations of Clinical Utility. Alfirevic, A; Pirmohamed, M // Clinical Pharmacology & Therapeutics;Sep2012, Vol. 92 Issue 3, p376 

    Genetic predisposition to drug-induced liver injury may be due to variation in both pharmacokinetic and pharmacodynamic pathways. Recent genome-wide association studies have identified, in the human leukocyte antigen (HLA) alleles, strong genetic factors that predispose to liver injury on...

  • Persistent Liver Biochemistry Abnormalities Are More Common in Older Patients and those With Cholestatic Drug Induced Liver Injury. Fontana, Robert J; Hayashi, Paul H; Barnhart, Huiman; Kleiner, David E; Reddy, K Rajender; Chalasani, Naga; Lee, William M; Stolz, Andrew; Phillips, Thomas; Serrano, Jose; Watkins, Paul B // American Journal of Gastroenterology;Oct2015, Vol. 110 Issue 10, p1450 

    Objectives:The long-term outcomes of patients with drug induced liver injury (DILI) are not well described. The aim of this study was to determine the frequency and severity of persistent liver biochemistry abnormalities in DILI patients followed over 2 years.Methods:Subjects with evidence of...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics